Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,807 | -2,343 | -14,369 | -11,252 | -5,913 |
| Depreciation Amortization | -34 | -7 | -288 | -312 | -328 |
| Other Working Capital | 291 | -683 | 149 | 230 | 76 |
| Other Operating Activity | -1,636 | -1,347 | -4,332 | -2,884 | -3,886 |
| Operating Cash Flow | $-6,187 | $-4,380 | $-18,839 | $-14,218 | $-10,051 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,888 | -5,888 | 11,950 | 9,950 | 6,250 |
| PPE Investments | -14 | -8 | -39 | -39 | -4 |
| Investing Cash Flow | $-2,901 | $-5,895 | $11,911 | $9,911 | $6,247 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,654 | 7,654 | 6,873 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -100 | 0 | 0 |
| Financing Cash Flow | $7,654 | $7,654 | $6,773 | $N/A | $N/A |
| Beginning Cash Position | 8,744 | 8,744 | 8,899 | 8,899 | 8,899 |
| End Cash Position | 7,310 | 6,123 | 8,744 | 4,592 | 5,094 |
| Net Cash Flow | $-1,434 | $-2,622 | $-155 | $-4,307 | $-3,805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,187 | -4,380 | -18,839 | -14,218 | -10,051 |
| Capital Expenditure | -19 | -13 | -39 | -39 | -4 |
| Free Cash Flow | -6,206 | -4,393 | -18,878 | -14,258 | -10,055 |